Contract modification No. 55, dated January 10, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United States Department of Health and Human Services dated February 16, 2011, as amended

EX-10.64 3 a20181231cmrxex1064.htm EXHIBIT 10.64 Exhibit
[...***...] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT,
MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO
RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.


AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
1. CONTRACT ID CODE
PAGE OF PAGES
1
 
3

2. AMENDMENT/MODIFICATION NO.
0055
3. EFFECTIVE DATE
See Block 16C
4. REQUISITION/PURCHASE REQ. NO
OS232949
5. PROJECT NO. (If applicable)

6. ISSUED BY
CODE
ASPR-BARDA
7. ADMINISTERED BY (if other than Item 6)
CODE
ASPR-BARDA02
ASPR-BARDA
200 Independence Ave., S.W.
Room 640-G
Washington DC 20201

ASPR-BARDA
330 Independence Ave, SW, Rm G640
Washington DC 20201
8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State, and ZIP Code)

CHIMERIX, INC. 1377270
CHIMERIX, INC. 2505 MERIDIAN P
2505 MERIDIAN PKWY STE 340
DURHAM NC ###-###-####


(x)
9A. AMENDMENT OF SOLICITATION NO.

9B. DATED (SEE ITEM 11)


x
10A. MODIFICATION OF CONTRACT/ORDER NO.
HHSO100201100013C
CODE:  1377270
FACILITY CODE:
10B. DATED (SEE ITEM 13)
02/16/2011
   11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
The above numbered, solicitation is amended as set forth in item 14. The hour and date specified for receipt of Offers                                    is extended is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended by one of the following methods: (a) By completing
Items 8 and 15, and returning          copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By
separate letter or telegram which includes a reference to the solicitation and amendment numbers, FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT
THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by
virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes
reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
12. ACCOUNTING AND APPROPRIATION DATA (If Required)   Net Increase: $2,340,571.00

See Schedule
 
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS, IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14
 
CHECK ONE

A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT 
ORDER NO IN ITEM 10A.
 
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, 
appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
 
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF
x
D. OTHER (Specify type of modification and authority)

Bilateral: Mutual Agreement of the Parties.
E. IMPORTANT: Contractor ¨ is not ý is required to sign this document and return          0    copies to the issuing office
 
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible)
Tax ID Number: 33-0903395
DUNS Number: 121785997
A. The purpose of this bilateral modification is to incorporate the following changes into the contract:

1. Add cost growth funding in the amount of $2,340,571.00 (No Fixed Fee) for the purpose of funding additional time for the completion of Option 2/CLIN 0003 under Contract Number HHSO100201100013C.

2. As a result of adding additional funding to Option 2/CLIN 0003 under Contract Number HHSO100201100013, Option 2/CLIN 0003 is here by revised as follows:
Continued …
 
Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
 
15A NAME AND TITLE OF SIGNER (type or print)

M. Michelle Berrey CEO
16A NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

ETHAN J. MUELLER
 
15B CONTRACTOR/OFFEROR

/s/ M. Michelle Berrey
15C DATE SIGNED

12/21/18
16B UNITED STATES OF AMERICA


/s/ Ethan J. Mueller
16C. DATE SIGNED


1/10/19
   (Signature of person authorized to sign)
 
   (Signature of Contracting Officer)
 
NSN 7540-01-152-8070                                        STANDARD FORM 30 (REV 10-83)
Previous edition unusable                                          Prescribed by GSA
FAR (48 CFR) 53.243

[...***...] = CERTAIN CONFIDENTIAL INFORMATION OMITTED



CONTINUATION SHEET
REFERENCE NO. OF DOCUMENT BEING CONTINUED
HHSO100201100013C/0055
PAGE OF
2
3
NAME OF OFFEROR OR CONTRACTOR
CHIMERIX, INC. 1377270
ITEM NO.
(A)
SUPPLIES/SERVICES
(B)
QUANTITY
(C)
UNIT
(D)
UNIT PRICE
(E)
AMOUNT
(F)
 
Total Estimated Cost: from $[...***...] By $2,340,571.00 to $[...***...].
No Change to the Total Fixed Fee of $[...***...].
Total Estimated Cost Plus Fixed Fee: From $[...***...] By $2,340,571.00 To
$[...***...].
3. This modification also results a change in the total amount of the contract from 
$[...***...] by $2,340,571.00 to $[...***...] as well as the following:
Total Estimated Cost of the Contract: From $[...***...] By $2,340,571.00 To 
$[...***...].
No Change to the Total Fixed Fee of $[...***...].
Total Estimated Cost Plus Fixed Fee of the Contract: From $[...***...] By 
$2,340,571.00 To $[...***...].
4. This modification hereby results in a increase in the total amount of the 
contract from $[...***...] By $2,340,571.00 to $[...***...].
5. Block 15G of the SF 26, the amount of $[...***...] shall be changed to 
$[...***...].
6. Also in Block 14 of the SF 26, the following CAN Number is added as follows:
Appropriation Year: 2019; Object Class: 25016; CAN 1992019 $2,340,571.00.
7. The period of performance for Option 2/CLIN 0003 of Contract Number 
HHSO100201100013C is hereby changed from 1 September 2014 through 30 March 2019 to 1 
September 2014 through 1 August 2019.
8. The Statement of Work under Contract Number HHSO100201100013 hereby remains 
unchanged.
9. For the Option 2/CLIN 0003, cost growth for this Modification 55, Total 
Estimated Cost (No Fixed Fee) - $2,340,571.00, Only, the following Indirect Cost 
Ceiling Rates are established for which Chimerix cannot seek reimbursement in excess 
of the following Indirect Cost Ceiling Rates:
[...***...]% Fringe, [...***...]% G&A
10. The total amount, scope and period of performance of all other CLINs that are 
currently being performed under the contract remain unchanged. This modification 
does not exercise any unexercised Option CLINs under the contract and does not 
authorize any performance of efforts under any unexercised Option CLINs under the 
contract. In addition, the total amount, scope and period of performance of all 
unexercised Option CLINs under the contract remain unchanged. This modification 
also confirms that all activities under the base period of performance CLIN 0001 
Continued ...
NSN 7540-01-152-8067     OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110

[...***...] = CERTAIN CONFIDENTIAL INFORMATION OMITTED



CONTINUATION SHEET
REFERENCE NO. OF DOCUMENT BEING CONTINUED
HHSO100201100013C/0055
PAGE OF
3
3
NAME OF OFFEROR OR CONTRACTOR
CHIMERIX, INC. 1377270
ITEM NO.
(A)
SUPPLIES/SERVICES
(B)
QUANTITY
(C)
UNIT
(D)
UNIT PRICE
(E)
AMOUNT
(F)



























3
were completed as of 31 May 2013 and confirms that all activities under the Option 
1/CLIN 0002 period of performance were completed as of 30 April 2015.
B. This is a bilateral modification. All other terms and conditions of Contract Number HHSO100201100013C remain unchanged.



Delivery Location Code: HHS
HHS
200 Independence Avenue, SW
Washington DC 20201 US

FOB: Destination
Period of Performance: 02/16/2011 to 08/01/2019

Change Item 3 to read as follows (amount shown is the obligated amount) :

[...***...] $2,340,571.00

Reports and other Data Deliverables.

Delivery: 11/30/2015
Amount: $16,951,226.00
Accounting Info:
2014.1992003.25106 Appr. Yr.: 2014 CAN: 1992003 Object Class: 25106
Funded: $0.00

Delivery: 06/30/2017
Amount: $535,016.00
Accounting Info:
2016.1992016.25103 Appr. Yr.: 2016 CAN: 1992016 Object Class: 25103
Funded: $0.00

Delivery 09/30/2018
Amount: $4,091,177.00
Accounting Info:
2018.1992018.25106 Appr. Yr.: 2018 CAN: 1992018 Object Class: 25106
Funded: $0.00

Delivery: 08/01/2019
Amount: $2,340,571.00
Accounting Info:
2019.1992019.25106 Appr. Yr.: 2019 CAN: 1992019 Object Class: 25106
Funded: $2,340,571.00

 
 
NSN 7540-01-152-8067     OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110


[...***...] = CERTAIN CONFIDENTIAL INFORMATION OMITTED